Neonate organisms display an intrinsic disability to mount effective immune responses to infectious agents or conventional vaccines. Whereas low. doses of antigens trigger a suboptimal response, higher doses are frequently associated with tolerance induction. We investigated the ability of a plasmid-expressing nucleoprotein of influenza virus to prime a specific cellular immune response when administered to newborn mice. We found that persistent exposure to antigen following plasmid inoculation of neonates leads to a vigorous priming of specific CTLs rather than tolerance induction. The CTLs were cross-reactive against multiple strains of type A influenza viruses and produced IFNy but no IL-4. The immunity triggered by plasmid inoculation of neonates was protective in terms of pulmonary virus clearance as well as survival rate following lethal challenge with influenza virus. Whereas the persistence of the plasmid at the site of injection was readily demonstrable in adult mice at 3 months after inoculation, mice immunized as newborns displayed no plasmid at 3 months and very little at month after injection. Thus, DNA-based immunization of neonates may prove an effective and safe vaccination strategy for induction of cellular immunity against microbes that cause serious infectious diseases in the early period of life.
INTRODUCTION
Various vaccine strategies were shown to induce a cytotoxic immune response in adult organisms. An effective induction of CTL immunity depends on the ability of the vaccine to direct the epitopes to the MHC-class I pathway of presentation (Townsend et al., 1985) . Live-attenuated recombinant vectors (Aggarwal et al., 1990; Tartaglia et al., 1992) , peptide or protein formulations in liposomes (Harding et al., 1991; Nair et al., 1992) , lipid-tailed peptides (Allsopp et al., 1996) , or recombinant Ty viruslike particles (Griffiths et al., 1991) promising strategy of vaccination tested in numerous experimental systems and able to trigger in adult organisms long-term cellular (Ulmer et al., 1993; Yankauckas et al., 1993) and humoral (Davis et al., 1993; Robinson et al., 1993) immunity with protective ability in some cases (Whalen, 1996) . DNAbased vaccination offers some advantages over the other vaccine strategies: ability to induce a CTL immune response in absence of vector replication and strong adjuvants, long duration of memory presumably due to the persistence of the antigen, and a relatively easy and rapid manufacture procedure that lowers the fabrication costs (Whalen, 1996) .
Compared with adults, young organisms display particular immune responsiveness to antigens. Early studies showed that newborns are very susceptible to tolerance induction for alloantigens (Billingham et al., 1956 ) and polysaccharides (Bona et al., 1978) (Adkins et al., 1993) or antigens (Barrios et al., 1996) , respectively. Further, high-zone tolerance in neonates was associated with a strong Th2 type of immune response (Forsthuber et al., 1996; Sarzotti et al., 1996) , suggesting that active suppressive mechanisms rather than precursor deletion may be responsible for neonatal low responsiveness to foreign antigens. Recent studies showed that targeting the antigen to professional antigen-presenting cells (APCs) (Ridge et al., 1996) , use of certain adjuvants (Forsthuber et al., 1996) , and decreasing the dose of immunogen (Sarzotti et al., 1996) were followed by induction of significant cellular immune responses in neonates. Thus, at least in some circumstances, immunization of newborns triggers Thl and CTL immune responses. In light of these recent studies, the particular immune responsiveness of newborns consisting in tolerance susceptibility and Th2-biased immune responses seems to be due to predominant presentation of antigen by nonprofessional APC rather than to intrinsic characteristics of neonatal T lymphocytes.
We investigated the ability of the NPV1 plasmidexpressing nucleoprotein (NP) of influenza virus strain A/PR8/34 (PR8) to induce cytotoxic immune responses following i.m. inoculation of newborn BALB/c mice. Previous studies showed that injection of NPV plasmid in adult mice primed a strong CTL response that protected the animals after challenge with a heterologous strain of influenza virus (Ulmer et al., 1993) . It is known that whereas hemagglutinin (HA) encodes the major B and Th epitopes responsible for the generation of protective antibodies (Virelizier, 1975) , NP and other inner proteins encode CTL epitopes that participate to the clearance of virus (Yap et al., 1978; Lin and Askonas, 1981; Lukacher et al., 1984) . It was shown that anti-NP antibodies do not mediate any protective effects (Epstein et al., 1993 Krug, 1989 (Taylor et al., 1987) (Cancro et al., 1979 CTL induced by qPV1 immunization of neonates displayed cross-reactivity against multiple type A strains of influenza virus and recognized the major cross-reactive NP 147-155 epitope. This is particularly important in the case of neonates, because of a high antigenic polymorphism of influenza virus strains faced by a limited ability of the immune system to respond to microbes in the early period of life. In spite of the cross-reactivity of CTLs induced by NPV1 immunization, a slightly reduced heterologous protection was demonstrated in mice immunized with NPV1 as adults or neonates. This may be due to a reduced magnitude of the crossreactive immunity conferred by NP in our experimental system and probably to a faster replication rate of the HK virus in the lungs. The discrepancy with a previous study, which showed complete heterologous protection (Ulmer et al., 1993) , may be explained by differences in the method of infection. It is known that aerosol challenge leads to an extensive infection of the upper and lower respiratory tract that can lead to fatal DTH lesions of the lungs (Sullivan et al., 1976) even in the case of successful virus clearance. Thus, our results showed that even if most of the mice immunized with NPV1 cleared the pulmonary virus by day 7 following lethal homologous or heterologous challenge, fewer of them survived and completely recovered. Effective early recruitment of the virusspecific CTL at the site of infection leads to rapid limitation of infection, prompt decrease of pulmonary virus titer, and reduced DTH lesions. Although a slower recruitment of specific CTLs may be still followed by a reduction of virus titer, DTH lesions tend to be more extensive and may cause the death of the animal.
I-I-i-I-I-I-I-I-I-I-I-I-I-I-I-I-I-I-I-
PCR analysis of DNA extracted from muscles at the site of injection showed a reduced persistence of NPV1 plasmid in mice injected as newborns. This could be due to either a faster degradation or to the lytic activity of CTLs toward somatic cells transfected with NPV 1. The latter hypothesis seems less probable because the efficiency of CTL priming was higher in adult mice that displayed longer persistency of the plasmid. Instead, in the case of newborns injected with DNA in the gluteal muscle, the limited persistency might be caused by a higher diffusion of the plasmid into the rapidly proliferating tissues or to the increased degradation. In contrast, the anterior tibial muscles of adult mice rich in conjunctive tissue and largely composed of nondividing myocytes may facilitate the retention of the plasmid over longer intervals. It is not clear yet what is the relationship between the persistency of the immunological memory, the plasmid at the site of injection, and the antigenic stimulation. Whereas some studies showed that the duration of the memory is strictly dependent on the continuous exposure to antigens (Gray and Matzinger, 1991; Oehen et al., 1992) , other studies indicated that memory cells represent a distinctive subset differentiated from naive cells following antigen priming (Akbar et al., 1988; Camp et al., 1991) .
DNA-based immunization presents some advantages over classical vaccine approaches currently employed in neonates and infants. Whereas inactivated and subunit vaccines prime mostly a humoral immune response, neonatal DNA vaccination with plasmids encoding NP and HA of influenza virus is followed by synergistic cellular and humoral immunity (manuscript in preparation) . Other strategies like the use of live-attenuated vectors (Aggarwal et al., 1990; Tartaglia et al., 1992) or strong adjuvants (Harding et al., 1991) lead to generation of CTL immunity, but side effects and cost-related problems may eventually limit their large-scale use. In the case of live-attenuated vaccines, the strong tendency of neonates to develop a Th2 type of immune response to some viral epitopes may explain the limited efficacy of CTL induction (Barrios et al., 1996) . The prolonged stimulation of the immune system following DNA injection may circumvent the requirement for boosts carried out in the case of inactivated vaccines and may lead to a long-term immunity. Regarding the possible side effects like oncogenesis, a recent study estimated that the rate of mutagenesis induced by DNA injection is significantly lower than the spontaneous chance of genome mutation (Nichols et al., 1995) (Isobe et al., 1994) . Virus titers were estimated by interpolation of the dilution that showed hemagglutination in 50% of wells (Reed and Muench, 1938 (Rosner, 1995 Supernatants were harvested and IFN,/ or IL-4 concentration was estimated by ELISA (BioSource, Camarillo, CA). In alternative protocols, CD4 T cells were previously depleted using magnetic beads coupled with goat anti-rat IgG (PerSeptive Diagnostics, Cambridge, MA) and rat anti-CD4 mAb (GK 1.5).
Plasmid Detection by PCR Injected and noninjected muscle tissues were removed 1 or 3 months after completion of immunization with NPV1 plasmid, immediately frozen in ethanol-dry ice and stored at -80C. Frozen tissue was thawed and homogenized in lysis buffer (25 mM Tris, 2 mM CDTA, 2 mM DTT, 10% glycerol, and 1% Triton X), as previously described (Ulmer et al., 1993) . After phenol-chloroform extraction of DNA, 40-cycle PCR reactions were carried out using a PCR Reagent System Kit (Life Technologies) with the following NP-specific primers:
forward:
5'-CATTGTCTAGAATTT-GAACTCCTCTAGTGG reverse:
5'-GGCCGTCGACCATGATGATCTGGcATTCC
